Oxytocin treatment in pediatric populations
Adrienne E Taylor1, Hsu-En Lee2, Femke T A Buisman-Pijlman3
1Department of Psychological Medicine, Women's and Children's Hospital Adelaide, SA, Australia.
Insights
Oxytocin, a neuromodulator, shows potential for pediatric mental health, but research on its effects and risks in developing brains is needed. This review examines intranasal oxytocin use in young populations and its clinical implications.
Area of Science:
- Neuroscience
- Pediatric Psychology
- Pharmacology
Background:
- Endogenous oxytocin is a key neuromodulator for social behaviors, birth, and lactation.
- Intranasal oxytocin administration shows promise for various mental health disorders in adults and animals.
- Pediatric applications of oxytocin are an emerging research frontier.
Purpose of the Study:
- To review the current understanding of endogenous oxytocin's role in behavior, particularly attachment.
- To examine literature on intranasal oxytocin use in young animals, children, and adolescents.
- To assess potential benefits, risks, and clinical implications of oxytocin in pediatric populations.
Main Methods:
- Literature review of studies on endogenous oxytocin and neuropeptide systems.
- Analysis of research on intranasal oxytocin administration in pediatric subjects (birth-19 years).
- Evaluation of existing data on risks, benefits, and psychopathology in children.
Main Results:
- Limited animal data exists on pediatric oxytocin use.
- Human studies on autism are ongoing, suggesting future therapeutic possibilities.
- Data on risks of repeated oxytocin use in developing brains is scarce.
Conclusions:
- Further research is crucial to understand oxytocin's effects on the developing brain and body.
- Clinical perspectives are needed to guide the safe and effective use of oxytocin in children.
- Careful consideration of risks is necessary, especially in vulnerable pediatric populations.
Abstract:
The role of endogenous oxytocin as neuromodulator of birth, lactation and social behaviors is well-recognized. Moreover, the use of oxytocin as a facilitator of social and other behaviors is becoming more and more accepted. Many positive effects have been attributed to intranasal oxytocin administration in animals and humans; with current research highlighting encouraging advances in its potential for use in mental health disorders. The new frontier will be investigating the effective use of oxytocin in pediatric populations. Limited animal data is available on this. Large-scale human studies focusing on autism are currently under way, but many other possibilities seem to lie in the future. However, we need to know more about the risks and effects of repeated use on the developing brain and body. This paper will provide an overview of the current understanding of the role of endogenous oxytocin and its related neuropeptide systems in influencing behaviors, in particular attachment, and will review (a) the literature on the use of intranasal oxytocin in young animals, children (age range birth-12 years) and adolescents (age range 13-19 years), (b) the expected benefits and risks based on the current research, and (c) the risks of oxytocin in children with severe psychopathology and early life trauma. The paper will conclude with a clinical perspective on these findings.
Related Concept Videos
01:29Drug Dosing: Infants and Children
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:31Neurotransmitters
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism